Overexpression of eIF1A1, eIF3D and eIF2B5 was observed in both the GCB and non-GCB-DLBCL subtypes, but was somewhat greater in non-GCB-DLBCL, and was confirmed by immunohistochemistry. This evidence concerns the gene EIF2B5 and diffuse large B-cell lymphoma.